Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. EBITDA 2020–2025
Enanta Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Enanta Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2026 was -8.6 M.
- Enanta Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2026 was -46.6 M.
- Enanta Pharmaceuticals Inc. annual ebitda for 2025 was -71.3 M, a 31.81% decrease from 2024.
- Enanta Pharmaceuticals Inc. annual ebitda for 2024 was -104.6 M, a 15.30% decrease from 2023.
- Enanta Pharmaceuticals Inc. annual ebitda for 2023 was -123.5 M, a 3.50% increase from 2022.
- Enanta Pharmaceuticals Inc. annual ebitda for 2022 was -119.3 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Enanta Pharmaceuticals Inc. EBITDA — FAQ
Enanta Pharmaceuticals Inc. (ENTA) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's ebitda history?
The chart and table above show Enanta Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.